Financial statements Neurofarma

Balance sheet of Neurofarma

Company age:
Age:
12 y. 19 d.
Share capital:
Share capital:
9 400 PLN
Profit and loss statement Balance Profitability

Balance sheet data of NEUROFARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 949 737,68 814 679,46 830 126,07 850 463,88 908 500,55 970 502,07
A. Fixed assets 281 909,86 132 845,75 105 633,76 78 421,77 54 968,85 45 501,14
B. Current assets 667 827,82 681 833,71 724 492,31 772 042,11 853 531,70 925 000,93
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 949 737,74 814 679,46 830 126,07 850 463,88 908 500,55 970 502,07
A. Equity -482 779,01 73 591,97 946,06 27 518,59 42 969,68 79 064,50
B. Liabilities and provisions for liabilities 1 432 516,75 741 087,49 829 180,01 822 945,29 865 530,87 891 437,57
I. Long-term liabilities 913 355,14 0,00 342 661,56 0,00 362 488,97 306 953,19
II. Short-term liabilities 490 790,17 741 087,49 486 518,45 822 945,29 503 041,90 584 484,38
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.